Cargando…
Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology
Aims: To evaluate the effectiveness and potential mechanism of calcium dobesilate (CaD) in diabetic kidney disease (DKD) patients. Methods: We searched for available randomized controlled studies on DKD patients’ treatment with CaD through open databases. Continuous variables were expressed as stand...
Autores principales: | Du, Bingyu, Yin, Yanyan, Wang, Yuqing, Fu, Hui, Sun, Helin, Yue, Zhaodi, Yu, Shaohong, Zhang, Zhongwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493050/ https://www.ncbi.nlm.nih.gov/pubmed/36160448 http://dx.doi.org/10.3389/fphar.2022.850167 |
Ejemplares similares
-
Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway
por: Yue, Zhaodi, et al.
Publicado: (2021) -
Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway
por: Wang, Yue, et al.
Publicado: (2019) -
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017) -
Calcium dobesilate-induced hyperpyrexia: A case report
por: Yang, Hui, et al.
Publicado: (2023)